dc.contributor.author
Oh, Djin-Ye
dc.contributor.author
Hölzer, Martin
dc.contributor.author
Börnigen, Daniela
dc.contributor.author
Paraskevopoulou, Sofia
dc.contributor.author
Duwe, Susanne
dc.contributor.author
Budt, Matthias
dc.contributor.author
Kerber, Romy
dc.contributor.author
Mikolajewska, Agata
dc.contributor.author
Böttcher, Sindy
dc.contributor.author
Seifried, Janna
dc.contributor.author
Haas, Walter
dc.contributor.author
Dürrwald, Ralf
dc.contributor.author
Fuchs, Stephan
dc.contributor.author
Kröger, Stefan
dc.contributor.author
von Kleist, Max
dc.contributor.author
Wolff, Thorsten
dc.contributor.author
Mielke, Martin
dc.date.accessioned
2026-01-05T12:42:57Z
dc.date.available
2026-01-05T12:42:57Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/50925
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-50652
dc.description.abstract
This review summarizes key virological parameters of SARS-CoV-2, the clinical spectrum of COVID-19, antiviral options, resistance, and the evolution of SARS-CoV-2 during the first four years of the pandemic. It draws on evidence that has been continuously updated throughout the pandemic by the interdisciplinary working group ‘SARS-CoV-2 Diagnostics and Evolution’ at Robert Koch Institute (RKI), Germany’s national public health institute. We describe basic SARS-CoV-2 characteristics and highlight notable virus variants from 2020 to mid-2023. During this period, the nationwide collection of SARS-CoV-2 genomes provided a substantial resource for monitoring viral lineage frequencies and mutations. We summarize this dataset to underscore the importance of virological surveillance in the context of public health and pandemic preparedness.
en
dc.format.extent
22 Seiten
dc.rights
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Viral epidemiology
en
dc.subject
Viral infection
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie::570 Biowissenschaften; Biologie
dc.title
A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023
dc.type
Wissenschaftlicher Artikel
dc.date.updated
2025-12-31T02:34:59Z
dcterms.bibliographicCitation.articlenumber
468
dcterms.bibliographicCitation.doi
10.1038/s43856-025-01093-1
dcterms.bibliographicCitation.journaltitle
Communications Medicine
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.volume
5
dcterms.bibliographicCitation.url
https://doi.org/10.1038/s43856-025-01093-1
refubium.affiliation
Mathematik und Informatik
refubium.affiliation.other
Institut für Mathematik
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2730-664X
refubium.resourceType.provider
DeepGreen
